However, clinicians should reconsider the indications for surgery in cases of PNs associated with NF-1 that are discontinued before medical treatment because of disease progression, adverse events, or suspected malignant transformation (e.g., MPNST). The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.